Avalo Therapeutics (AVTX) EBITDA Margin Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -480,275.00 |
| Dec 31, 2024 | -1.71 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Dec 31, 2023 | -35,287.00 |
| Sep 30, 2023 | -223,661.00 |
| Jun 30, 2023 | -1,697.00 |
| Mar 31, 2023 | -21,591.00 |
| Dec 31, 2022 | 721,400.00 |
| Sep 30, 2022 | 124,083.00 |
| Jun 30, 2022 | -74,666.00 |
| Mar 31, 2022 | 458,524.00 |
| Dec 31, 2021 | -711,083.00 |
| Sep 30, 2021 | -2,443.00 |
| Jun 30, 2021 | 37,248.00 |
| Mar 31, 2021 | -532,448.00 |
| Dec 31, 2020 | -10,613.00 |
| Sep 30, 2020 | -106,505.00 |
| Jun 30, 2020 | -69,998.00 |
| Mar 31, 2020 | -94,637.00 |
| Dec 31, 2019 | -101,000.00 |
| Sep 30, 2019 | 46,668.00 |
| Jun 30, 2019 | -6,284.00 |
| Mar 31, 2019 | -11,051.00 |
| Dec 31, 2018 | 25,267.00 |
| Sep 30, 2018 | -68,423.00 |
| Jun 30, 2018 | 100,462.00 |
| Mar 31, 2018 | 41,055.00 |
| Dec 31, 2017 | 69,857.00 |
| Sep 30, 2017 | 194,241.00 |
| Jun 30, 2017 | -58,862.00 |